A Study to Evaluate the Efficacy and Safety of Hetrombopag Olamine Tablets Vs Placebo in Patients With Chemotherapy-Induced Thrombocytopenia (ExCIT)
Public ClinicalTrials.gov record NCT07286032. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Multi-Center, Double-Blind, Phase III Study Evaluating the Efficacy and Safety of Hetrombopag Olamine Tablets Vs Placebo in Patients With Chemotherapy-Induced Thrombocytopenia
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The ExCIT study is being conducted to evaluate the efficacy, and safety of of Hetrombopag Olamine Tablets Vs Placebo in Patients with Chemotherapy-Induced Thrombocytopenia.
Study identification
- NCT ID
- NCT07286032
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 150 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 16, 2026 (Actual)
- Primary completion
- Dec 2028 (Estimated)
- Completion
- Jun 2029 (Estimated)
- Last update posted
- Oct 1, 2026
2026 – 2029
United States locations
- U.S. sites
- 14
- U.S. states
- 8
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Starling Oncology | Long Beach | California | 90805 | Not yet recruiting |
| Cancer and Blood Specialty Clinic | Los Alamitos | California | 90254 | Recruiting |
| UCLA | Los Angeles | California | 90095 | Recruiting |
| Clermont Oncology Center | Clermont | Florida | 34711 | Recruiting |
| Oncology & Hematology Associates of West Broward | Coral Springs | Florida | 33065 | Recruiting |
| Starling Oncology / Oncology Institute of Hope & Innovation | Miami | Florida | 33141 | Not yet recruiting |
| Mid-Florida Hematology & Oncology Centers, P.A. | Orange City | Florida | 32763 | Recruiting |
| Springfield Clinic | Springfield | Illinois | 62702 | Recruiting |
| University of Iowa | Iowa City | Iowa | 52242 | Recruiting |
| Hattiesburg Clinic Hematology/Oncology | Hattiesburg | Mississippi | 39401 | Not yet recruiting |
| Cancer Partners of Nebraska | Lincoln | Nebraska | 68516 | Recruiting |
| Morristown Medical Center | Morristown | New Jersey | 07039 | Not yet recruiting |
| MSK Cancer Center | New York | New York | 10065 | Not yet recruiting |
| New York Cancer and Blood Specialists One Oncology | Shirley | New York | 11967 | Not yet recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 37 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07286032, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 1, 2026 · Synced Nov 10, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT07286032 live on ClinicalTrials.gov.